Conference Highlights: IAS 2021
New research was presented at IAS 2021, the virtual 11th International AIDS Society Conference on...
Read More
HIV/AIDS
Chronic High-Risk Prescription Opioid Use in Patients With HIV
A study has found that opioid prescriptions, including receipt of prescriptions for long...
Read More
Hepatocellular Carcinoma & HIV
Hepatocellular carcinoma (HCC) is the fourth most prevalent cause of cancer-related death...
Read More
Amenorrhea & Bone Mineral Density in Women With HIV
Although previous studies indicate that HIV is a risk factor for missed menstrual periods, or...
Read More
HIV Infection & Cancer Outcomes Among the Elderly
Despite treatment, elderly patients with cancer who are HIV-positive had worse outcomes than those...
Read More
Immunologic Non-Response Despite Viral Suppression
For HIV-positive individuals who begin antiretroviral therapy (ART) at CD4 counts below 500...
Read More
Conference Highlights: IDWeek 2019
New research was presented at IDWeek 2019, the joint annual meeting of the Infectious Diseases...
Read More
Racial Disparities in HIV Incidence Among MSM
Despite overall progress in HIV prevention and treatment, the condition continues to...
Read More
Hepatitis and HIV Among Patients With Newly Diagnosed Cancer
Screening patients with newly diagnosed cancer to identify hepatitis B and C infections before...
Read More
Conference Highlights: IAS 2019
New research was presented at IAS 2019, the 10th International AIDS Society Conference on HIV...
Read More
Conference Highlights: ASM Microbe 2019
New research was presented at ASM Microbe 2019, the joint annual meeting of the American Society...
Read More
Prior Training Increases Internists’ Knowledge of PrEP for HIV
IM residents with training report more frequent prescribing, higher comfort level in educating patients
Read More
AIDS drugs prevent sexual transmission of HIV in gay men
By Kate Kelland LONDON (Reuters) – A European study of nearly 1,000 gay male couples who had...
Read More
April 2019 Briefing – HIV & AIDS
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for April 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Gender Differences Seen in Adverse Drug […]
Read More
‘Vampire Facials’ at New Mexico Spa Linked to HIV Infections
Facial involves injecting nutrient-rich plasma into the face using a microneedling pen
Read More
GSK wins U.S. nod for two-drug HIV combination
By Ludwig Burger (Reuters) – GlaxoSmithKline Plc’s two-drug treatment for HIV...
Read More
First Two-Drug Regimen Approved for HIV-1 Treatment
Dovato indicated for use in patients with no history of antiretroviral treatment
Read More
Conference Highlights: CROI 2019
New research was presented at CROI 2019, the annual Conference on Retroviruses and Opportunistic...
Read More
Associations With Kaposi Sarcoma in Patients With HIV
As of 2010, Kaposi sarcoma (KS) accounted for 12% of cancer diagnoses in people living with HIV or...
Read More
Improving HIV Outcomes With HIE
By Andy Skean Senior Editor Numerous studies have illustrated the ability of antiretroviral...
Read More